In Vitro Fertilization Market to Reach USD 1.94 Billion by 2034, Growing at a 9% CAGR

In Vitro Fertilization Market

The global in vitro fertilization (IVF) market is poised for significant growth, projected to rise from a valuation of USD 819.8 million in 2024 to an impressive USD 1,940.8 million by 2034. This expansion, driven by a compound annual growth rate (CAGR) of 9% during the forecast period, is fueled by the increasing prevalence of infertility and advancements in reproductive technologies.

Rising infertility rates, attributed to factors such as changing lifestyles, delayed parenthood, and environmental influences, are creating a surge in demand for IVF treatments. The market is further supported by advancements in assisted reproductive technologies (ART), including enhanced cryopreservation techniques, genetic testing, and improved success rates of embryo transfer.

Government initiatives, increasing awareness about infertility treatments, and the growing acceptance of IVF are also contributing to the market’s robust growth. Additionally, the development of affordable treatment options and the expansion of fertility clinics in emerging markets are expected to drive accessibility and adoption globally.

Key Takeaways:

• The global in vitro fertilization market is expected to grow from USD 819.8 million in 2024 to USD 1,940.8 million by 2034, at a CAGR of 9%.
• Rising infertility rates and advancements in assisted reproductive technologies are key drivers of market growth.
• Government support, increased awareness, and affordability initiatives are boosting accessibility to IVF treatments.
• Expansion of fertility clinics in emerging economies is expected to broaden the market’s reach.

Competitive Analysis

Major in vitro fertilization vendors invest in research and development to broaden their product portfolio, which assists the industry growth. The IVF providers are taking an assortment of strategic plans to expand their global presence, with key sector advancements like novel product introduction, partnership agreements, mergers and acquisitions, surged investments, and alliances with other firms.

The in vitro fertilization providers provide economical items to widen and endure in a progressively competitive and escalating market scenario. A primary business approach used by vendors to aid clients and magnify the sector is to produce regionally to curb production prices. The in vitro fertilization market has equipped medicine with some noteworthy advantages during the forecast period.

Request a Sample Copy Now : https://www.fmisamplereport.com/sample/rep-gb-14305

Prominent In Vitro Fertilization Providers

• Vitrolife
• Thermo Fisher Scientific Inc.
• Cook Group
• IVFtech ApS
• Esco Micro
• Genea Limited
• Fujifilm Irvine Scientific
• The Baker Company
• Kitazato Corporation

Key Segments

By Product:

The market is classified based on equipment, reagents & media, and accessories.

By Cycle:

The segment is categorized based on fresh non-donor cycle, frozen non-donor IVF cycle, frozen donor IVF cycle, and fresh donor IVF cycle.

By End User:

The report consists of key end-users based on fertility clinics, hospitals & surgical centers, and cryobank & research institutes.

By Type:

The market is classified into conventional IVF, IVF with ICSI, and IVF with donor eggs.

By Region:

Analysis of the in vitro fertilization market has been carried out in key countries of North America, Latin America, Middle East and Africa, Asia Pacific, and Europe.

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube